Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-13 Sale | 2026-07-13 4:06 pm | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 85,153 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:05 pm | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 177,523 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:05 pm | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 164,472 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:05 pm | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 141,023 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:04 pm | Esperion Therapeutics Inc. | ESPR | THOMPSON JOHN CRAIG Director | 79,873 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:04 pm | Esperion Therapeutics Inc. | ESPR | Harlow John B. Jr. Chief Commercial Officer | 424,536 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:04 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin Chief Legal Officer | 667,524 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 705,410 | $0 | $0 | 0 (Direct) | View |
| 2026-07-13 Sale | 2026-07-13 4:03 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 2,121,094 | $0 | $0 | 0 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin Chief Legal Officer | 11,824 | $3.155 | $37,305 | 667,524 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 53,588 | $3.155 | $169,070 | 2,119,111 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:05 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 10,773 | $3.155 | $33,989 | 702,829 (Direct) | View |
| 2026-03-17 Sale | 2026-03-18 4:13 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin Chief Legal Officer | 5,708 | $2.703 | $15,429 | 679,348 (Direct) | View |
| 2026-03-17 Sale | 2026-03-18 4:13 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 25,578 | $2.719 | $69,547 | 2,172,699 (Direct) | View |
| 2026-03-17 Sale | 2026-03-18 4:12 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 6,424 | $2.705 | $17,377 | 713,602 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 5:17 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,689 | $2.882 | $4,868 | 384,216 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:10 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 48,244 | $3.673 | $177,200 | 1,470,587 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:09 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,337 | $3.667 | $26,905 | 467,525 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:09 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,517 | $3.667 | $23,898 | 385,905 (Direct) | View |
| 2025-10-17 Sale | 2025-10-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,248 | $2.6245 | $3,275 | 392,422 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,267 | $2.804 | $17,573 | 393,670 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 28,427 | $2.788 | $79,254 | 1,518,831 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,046 | $2.808 | $19,785 | 474,862 (Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:07 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,304 | $1.127 | $1,470 | 399,937 (Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:05 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.115 | $12 | 474,462 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:45 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,422 | $1.152 | $7,398 | 401,241 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:44 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 30,474 | $1.109 | $33,796 | 1,541,488 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:44 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,229 | $1.152 | $8,328 | 474,473 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-28 Option Award | 2026-06-01 4:24 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | THOMPSON JOHN CRAIG Director | 79,873 | $0 | 79,873 (Direct) | View |
| 2026-05-28 Option Award | 2026-06-01 4:23 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 79,873 | $0 | 164,472 (Direct) | View |
| 2026-05-28 Option Award | 2026-06-01 4:23 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 79,873 | $0 | 85,153 (Direct) | View |
| 2026-05-28 Option Award | 2026-06-01 4:23 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 79,873 | $0 | 141,023 (Direct) | View |
| 2026-05-28 Option Award | 2026-06-01 4:22 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 79,873 | $0 | 177,523 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-16 4:20 pm | N/A 2036-03-13 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin Chief Legal Officer | 570,070 | $0 | 954,286 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-16 4:20 pm | N/A 2036-03-13 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 1,371,220 | $0 | 2,845,737 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-16 4:19 pm | N/A 2036-03-13 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 468,700 | $0 | 941,296 (Direct) | View |
| 2025-12-04 Option Award | 2025-12-08 4:27 pm | N/A 2035-12-04 | Esperion Therapeutics Inc. | ESPR | Harlow John B. Jr. Chief Commercial Officer | 804,536 | $0 | 804,536 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 08:21 am | N/A 2035-07-01 | Esperion Therapeutics Inc. | ESPR | THOMPSON JOHN CRAIG Director | 40,000 | $0 | 40,000 (Direct) | View |